In accordance with the results in MDS [12], SLIT2 promoter methylation was also correlated with advanced clinical stage of CML, and played a crucial role in disease progression. This evidence concerns the gene SLIT2 and chronic myelogenous leukemia, BCR-ABL1 positive.